These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5267639)

  • 21. Search for tumor specific reactivity in human leukemias.
    Nadkarni JS; Nadkarni JJ; Gollerkeri MP
    Indian J Cancer; 1973 Sep; 10(3):338-45. PubMed ID: 4594680
    [No Abstract]   [Full Text] [Related]  

  • 22. Isohaemagglutinin anti-A and anti-B, and serum complement levels in children with leukaemia.
    Kubiková-Kourilová A; Bĕlusa M
    Acta Paediatr Acad Sci Hung; 1970; 11(3):319-22. PubMed ID: 5525405
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera.
    Herberman RB; Nam JM
    J Natl Cancer Inst; 1971 Aug; 47(2):489-94. PubMed ID: 5283788
    [No Abstract]   [Full Text] [Related]  

  • 24. The immunodiagnosis of leukemia.
    Pisciotta AV; Cronkite C; Pryor S; Wilson B
    Transplant Proc; 1980 Mar; 12(1):198-204. PubMed ID: 6989057
    [No Abstract]   [Full Text] [Related]  

  • 25. Mixed leukocyte reactivity and leukemia: study of identical siblings.
    Rudolph RH; Mickelson E; Thomas ED
    J Clin Invest; 1970 Dec; 49(12):2271-5. PubMed ID: 5273804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro cellular immune reactivity of soluble antigens obtained from cultured leukemic cells in chronic myeloid leukemia.
    Khare AG; Advani SH; Gangal SG
    Indian J Exp Biol; 1981 Jun; 19(6):524-7. PubMed ID: 6944272
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukemia-associated antigens in leukemic transformation of polycythemia vera.
    Pisciotta AV; Cronkite C; Hanson GA; Brodsky JB; Donovan PB; Wasserman LR
    J Lab Clin Med; 1983 Mar; 101(3):432-40. PubMed ID: 6827175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on antigens of C-type primate viruses and antibodies to them at patients with myeloid leukemia and potentially preleukemic hematological disorders.
    Váczi L; Tóth FD
    Arch Geschwulstforsch; 1980; 50(8):769-77. PubMed ID: 6261716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of leukemic cells from rat bone marrow using antibody and complement.
    Feeney M; Knapp RC; Greenberger JS; Bast RC
    Cancer Res; 1981 Sep; 41(9 Pt 1):3331-5. PubMed ID: 6942913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the use of chemically tagged normal white blood cells as antigens for producing specific immune response against human leukemic cells.
    Sahasrabudhe MB; Prema S; Madyastha KR; Gollerkeri MP
    Indian J Cancer; 1972 Jun; 9(2):101-11. PubMed ID: 4629010
    [No Abstract]   [Full Text] [Related]  

  • 31. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on immunoglobulins in leukemic patients.
    Szmigiel Z
    Acta Med Pol; 1971; 12(4):503-22. PubMed ID: 5293503
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lymphocyte blastogenesis in vitro in leukemias and lymphomas of childhood].
    Fabris C; De Sanctis C; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):194-8. PubMed ID: 5280413
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of MLR-S in human myeloid, monocytic and erythroid cell differentiation.
    Han T; Minowada J
    J Clin Lab Immunol; 1980 Nov; 4(3):169-73. PubMed ID: 6451711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.
    Wahren B; Gahrton G; Hammarström S
    Cancer Res; 1980 Jun; 40(6):2039-44. PubMed ID: 6929221
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
    Marinov J; Koubek K; Starý J
    Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
    Martens AC; Johnson RJ; Kaizer H; Hagenbeek A
    Exp Hematol; 1984 Sep; 12(8):667-71. PubMed ID: 6386506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two cases of leukemia associated with disseminated intravascular coagulation (DIC) and hypocomplementemia--with special reference to the relationship between DIC and complement (author's transl)].
    Ishizaki T; Hashizume K; Kometani M; Tanaki T; Oba N; Numata T; Matsubara F; Shiobara S; Tejima H; Odaka K; Tsukuda K; Hattori K
    Rinsho Ketsueki; 1980 Aug; 21(8):1146-55. PubMed ID: 6934324
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on antigenic properties of normal and leukemic human leukocytes by the complement fixation technic].
    MILGROM F; SELIGMANN M; BERNARD J; GRABAR P
    Rev Hematol; 1959; 14():309-23. PubMed ID: 14422383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.